Summary
The use of sensor-augmented pump therapy resulted in significant decreases in HbA1C compared with multiple daily injection therapy across age groups, according to findings from the Sensor-Augmented Pump Therapy for A1C Reduction 3 [STAR 3; NCT00406133].
- Hyperglycemia/Hypoglycemia
- Diabetes Mellitus
- Diabetes & Endocrinology Clinical Trials
- © 2010 MD Conference Express
Tools
Table of contents
Cited By...
- No citing articles found.